Charles FERTE

美国MedImmune公司免疫肿瘤早期临床开发医学总监

Charles Ferte MD PhD is a medical director in early clinical development Immuno-Oncology at MedImmune (Gaithersburg, MD). He is currently leading the clinical development of multiple immune oncology assets (phase 1-2) and platform trials. He has more than 10 years of R&D experience in oncology drug development (both in academic & pharmaceutical industry environments). Before joining AstraZeneca, he was working at Institut Gustave Roussy (Paris, France) as a physician scientist. He was a senior attending physician - medical oncologist in the early drug development, GI and Head and Neck units. He also held the position of research group leader (radiomics team) in the INSERM U1030 unit. Thanks to an NCI-ICBP post-doctoral fellowship focusing on cancer systems biology at Sage Bionetworks - Fred Hutchinson Cancer research center (Seattle, WA), where he developed deep expertise both in molecular cancer biology and in bioinformatics/machine learning. From 2015-2017, he was an associate editor for Annals of Oncology (IF = 13.9;). He authored/co-authored more than 60 research articles in prestigious journals such as Lancet Oncology, Cancer Discovery, Annals of Oncology, Nature Reviews Clinical Oncology, Clinical Cancer Research & Invest New Drugs. He was the recipient of multiple awards from ASCO, ESMO, etc.

殷晓璐

阿斯利康精准医学部中国区肿瘤研发总监, 精准医学部诊断开发中国区负责人

Working experience: Director, Head of Precision Medicine Diagnostic Development, China (>2 year) Head of Biomarker Team/Histopathology Function, Innovation Centre China (ICC), Astrazeneca (10 years) Clinical pathologist in Renji Hospital, affiliated to Shanghai JiaoTong University (14 years) Lucy is expertise in following area: Clinical Pathology Precision Medicine Diagnostics in Clinical Study Translational Science PD/POM/POP in Preclinical Drug Discovery Education background: MD. Medicine in Shanghai JiaoTong University PhD. Molecular Pathology in the Chinese University of Hong Kong Post-doc. Molecular biology in Johns Hopkins University, USA

王玥

阿斯利康全球肿瘤研发中国研发统计部负责人兼副总裁

陈之键

阿斯利康全球新药研发高级副总裁及中国新药开发部总裁